Skip to main content

Roche’s virtual Neuroscience Update IR Event

Roche has hosted a virtual event on Monday, 30 October 2023.

Agenda
WelcomeBruno Eschli, Head of Investor Relations
Neuroscience Strategy UpdatePaulo Fontoura, SVP and Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases Clinical Development
MS - ECTRIMS data reviewStephen L. Hauser, Director, UCSF Weill Institute of Neurosciences
AD - CTAD data reviewLuka Kulic, Therapeutic Area Leader Dementias, Medical Director Neuroscience and Rare Diseases
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events, Past IR Events

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments.

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.